# Pandemic good news Page: https://stenobird.com/podcast/dr-john-campbell-7851784/pandemic-good-news Text version: https://stenobird.com/podcast/dr-john-campbell-7851784/pandemic-good-news.md Podcast: [Dr. John Campbell](https://stenobird.com/podcast/dr-john-campbell-7851784) Published: 2026-07-22T21:30:00+00:00 Episode link: https://traffic.megaphone.fm/VG8155022646.mp3 Audio file: https://traffic.megaphone.fm/VG8155022646.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/pandemic-good-news Duration seconds: 745 ## Resource CDC variant report https://covid.cdc.gov/covid-data-tracker/#variant-proportions Some increase in BA.4.6 and BA.2.75 BA.4.6 Progressive US increase, starting to slowly displace BA.5 US of America (9,526) Canada (1,007) Denmark (500) France (400) Australia (288) Germany (248) Chile (242) Dominican Republic (173), Peru (149), Luxembourg (123), Belgium (102), Israel (101), Italy (94), Ireland (93), Sweden (92), Spain (85), Netherlands (84), Brazil (76), Argentina (68), Japan (67), New Zealand (60), Switzerland (54), Puerto Rico (53), South Africa (53), Ecuador (49), Mexico (35), Colombia (34), Trinidad and Tobago (30), Czech Republic (27), Costa Rica (23), Jamaica (21), Portugal (20), South Korea (19), Austria (17), Botswana (17), Indonesia (13), Sint Maarten (12), Senegal (11) BA.2.75 Some US increase Growth rate is currently 61% per week relative to co-circulating lineages Current US nowcast BA.5 84.8% (UK, 87.2%) BA.4.6 10.3% (UK, 3.3) BA.4 1.8% BF.7 1.7% BA.2.75 1.3% (UK, 1.6%) BA.2 0% (UK, 0.5%) BA.1s 0% Delta 0% Others 0% (UK, 2.4%) XE 0% UK, technical briefing 45 (September 2022) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1103869/Technical-Briefing-45-9September2022.pdf Contains early data and analysis on emerging variants Findings have a high level of uncertainty Data cut-off of 5 September 2022 BA.5 BA.5 is the predominant circulating variant in the United Kingdom Newly designated variant – V-22SEP-01 (BA.4.6) Omicron sub-lineage BA.4.6 An apparent small growth advantage relative to BA.5. BA.4.6 represented 3.31% of UK samples Preliminary neutralisation data from BA.4.6 Expect some immune escape from BA.4 or BA.5 antibodies There is NO increased risk of hospital admission after BA.4 or BA.5 infection compared tâ€Ĥ ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/pandemic-good-news/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/dr-john-campbell-7851784/pandemic-good-news.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.